特别的扣押式的呈现Torsades De Pointes的点点
Kanchan Kanchan1, Ahmed Mohamed1, Pawan Kumar2
1Cardiology, University Hospitals Birmingham, Birmingham, GBR.
Cureus
|February 17, 2025
概括
一个罕见的案例突出显示,类似发作的发作可能是由Torsades de Pointes (TDP) 引起的,TDP是一种心律失常. 及时诊断和治疗,包括抗节律障碍药物和冠状动脉支架,对于管理这种情况至关重要.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 心脏电生理学 心脏电生理学
背景情况:
- 类似发作的发作可以呈现异常.
- 心律不整,如Torsades de Pointes (TDP),可以模仿神经事件.
- R-on-T 现象是一种特定的心电图发现,与心室心律不整的风险增加有关.
研究的目的:
- 报告一种罕见的Torsades de Pointes (TDP) 病例,呈现为类似的发作.
- 强调考虑心律失常在发作表现的差异诊断中的重要性.
- 为了说明TDP二次冠状动脉疾病的综合管理策略.
主要方法:
- 一个40岁的男性的病例报告.
- 电心电图 (ECG) 分析显示了R-on-T现象.
- 在Torsades de Pointes (TDP) 的诊断.
- 用抗心律失常药物和冠状动脉支架进行治疗.
主要成果:
- 这位患者的类似发作的发作被诊断为Torsades de Pointes (TDP).
- 通过抗心律失常药物实现了TDP的成功管理.
- 冠状动脉狭窄症被确定并用支架进行治疗.
- 患者从事件中恢复过来.
结论:
- 在非典型呈现的差异诊断中,应考虑Torsades de Pointes (TDP).
- 电脑电图上的R-on-T现象可以预测危及生命的心律失常.
- 涉及心脏病学和干预程序的多学科方法是有效的,用于管理TDP的复杂病例与潜在的冠状动脉疾病.
相关概念视频
Seizures: Classification
297
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
297
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
889
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
889
Antiepileptic Drugs: Sodium Channel Blockers
352
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
352
Antiepileptic Drugs: Calcium Channel Blockers
294
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
294
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
761
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
761


